Literature DB >> 29335543

Genetics of lipid metabolism in prostate cancer.

Ninu Poulose1, Francesca Amoroso1, Rebecca E Steele1, Reema Singh1, Chee Wee Ong1, Ian G Mills2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29335543     DOI： 10.1038/s41588-017-0037-0

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  11 in total

1.  Lipid Metabolism and Immune Checkpoints.

Authors:  Qianjin Liao; Yujuan Zhou; Longzheng Xia; Deliang Cao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer.

Authors:  Alejandro Schcolnik-Cabrera; Daniel Juárez-López
Journal:  Cell Oncol (Dordr)       Date:  2022-08-29       Impact factor: 7.051

3.  HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer.

Authors:  Xiaodong Lu; Ka-Wing Fong; Galina Gritsina; Fang Wang; Sylvan C Baca; Lourdes T Brea; Jacob E Berchuck; Sandor Spisak; Jenny Ross; Colm Morrissey; Eva Corey; Navdeep S Chandel; William J Catalona; Ximing Yang; Matthew L Freedman; Jonathan C Zhao; Jindan Yu
Journal:  Nat Genet       Date:  2022-04-25       Impact factor: 41.307

4.  Traditional Herbal Formula Taeeumjowi-Tang (TJ001) Inhibits p53-Mutant Prostate Cancer Cells Growth by Activating AMPK-Dependent Pathway.

Authors:  Sooyeon Kang; Hyo In Kim; Yu-Jeong Choi; Seul Ki Lee; Ji Hye Kim; Chunhoo Cheon; Seong-Gyu Ko
Journal:  Evid Based Complement Alternat Med       Date:  2019-05-05       Impact factor: 2.629

5.  Targeting PLA2G16, a lipid metabolism gene, by Ginsenoside Compound K to suppress the malignant progression of colorectal cancer.

Authors:  Li Yang; Lingjie Zheng; Xiaonv Xie; Junjia Luo; Jing Yu; Lihua Zhang; Wenhui Meng; Yingen Zhou; Ling Chen; Dongsheng Ouyang; Honghao Zhou; Zhirong Tan
Journal:  J Adv Res       Date:  2021-06-12       Impact factor: 10.479

6.  Adipocyte-driven unfolded protein response is a shared transcriptomic signature of metastatic prostate carcinoma cells.

Authors:  Mackenzie K Herroon; Shane Mecca; Alex Haimbaugh; Laimar C Garmo; Erandi Rajagurubandara; Sokol V Todi; Tracie R Baker; Izabela Podgorski
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2021-07-16       Impact factor: 5.011

7.  Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells.

Authors:  Prashanth K B Nagesh; Pallabita Chowdhury; Elham Hatami; Shashi Jain; Nirnoy Dan; Vivek Kumar Kashyap; Subhash C Chauhan; Meena Jaggi; Murali M Yallapu
Journal:  Sci Rep       Date:  2020-01-22       Impact factor: 4.379

Review 8.  Role of de novo cholesterol synthesis enzymes in cancer.

Authors:  Jie Yang; Lihua Wang; Renbing Jia
Journal:  J Cancer       Date:  2020-01-17       Impact factor: 4.207

9.  SREBP1 siRNA enhance the docetaxel effect based on a bone-cancer dual-targeting biomimetic nanosystem against bone metastatic castration-resistant prostate cancer.

Authors:  Jiyuan Chen; Zhenjie Wu; Weihong Ding; Chengwu Xiao; Yu Zhang; Shen Gao; Yuan Gao; Weimin Cai
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

10.  Serum untargeted lipidomics by UHPLC-ESI-HRMS aids the biomarker discovery of colorectal adenoma.

Authors:  Hailin Zhou; Yanying Nong; Yifan Zhu; Yunxiao Liang; Jiahao Zhang; Hongwei Chen; Pingchuan Zhu; Qisong Zhang
Journal:  BMC Cancer       Date:  2022-03-24       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.